I have an acquaintance. She’s a lot younger than me. I like her, but she’s one of those people who thinks she’s a rebel by doing things which are annoyingly conventional for women her age. I try not ...

Last last week, we wrote a piece about a company called Xicoia, one of what feels like nine billion AI video production companies currently trying to goldrush the planet to an early grave. The company ...

A pair of industrial and commercial roofing companies have merged in a deal that creates a group with a turnover of more than £20m operating from five offices across the UK. Roofclad Systems is ...

A former funeral director and hospital wardsman has admitted to a series of sexual attacks on women in Sydney in the early 90s, after a familial DNA link led to his arrest more than three decades on.

SM’s male trainee group SMTR25 is set to star in a brand-new reality show! On September 17, it was announced that SM Entertainment and production company eggiscoming are joining forces for the first ...

Baxdrostat 1 mg or 2 mg once daily led to statistically significant reductions in blood pressure compared with placebo at 12 weeks in patients with uncontrolled or treatment-resistant hypertension, ...

Whether you're a student, a fresh graduate, or transitioning careers, building a solid LinkedIn presence is one of the smartest career moves you can make. P Pulse Mix Follow In today’s digital-first ...

INDIANAPOLIS — "Paws" what you're doing and help an explosive detection canine at the Indianapolis International Airport win a contest! Voting is underway for the Transportation Security ...

Two male Vikings cheerleaders don’t seem to be taking any of the backlash that they’ve gotten from some football fans to heart since the team announced their inclusion in the 2025 squad in a post on ...

The underappreciated linebacker was a defensive star. Also, a "tweener" who forced his way onto the field. Let’s focus on Polk, a 250-pound bruiser with deceptive speed and a strong nose for the ...

Cellebrite offers a strong risk-reward profile after recent corrections, supported by robust execution and financials despite weak sentiment and macro headwinds. The company’s leadership in digital ...

Abivax SA (NASDAQ:ABVX) stock is skyrocketing on Wednesday after the clinical-stage biotechnology company announced overwhelmingly positive topline results from its Phase 3 ABTECT-1 (Study 105) and ...